Sartorius, DE0007165631

Sartorius stock rises 1.26 percent after the close

Published on 09/22/2026 at 23:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

After the close on September 22, 2026, Sartorius stock was last quoted at USD 200.50, up 1.26 percent on Investing.com. The S&P 500 comparison and the next trading day remain relevant for the U.S.-listed security.

Fotorealistische Bioreaktor-Anlage in Reinraumhalle mit Edelstahltanks und Technikern
Sartorius AG (Vz.) DE0006292006 zeigt fotorealistisch eine sterile Bioreaktor-Anlage mit Technikern in weißer Reinraum-Schutzkleidung, Illustration mit AI erstellt.

The U.S.-listed shares of Sartorius were last quoted at USD 200.50, up 1.26 percent on September 22, 2026, according to the U.S. market quote shown by Investing.com. The quote is presented as a current market value rather than a confirmed official regular-session close. The company therefore enters the evening with the U.S. market comparison as the key reference.

September 22, 2026 market context

Sartorius AG (ISIN DE0007165631) was also reported at EUR 248.70 on Xetra on September 21, 2026, up 0.57 percent from EUR 247.30, but that home-market value is not the U.S. close for this article. Ad Hoc News reported the Xetra comparison in its September 22 coverage.

The U.S. market backdrop included a Nasdaq close of 27,122.09 points, up 2.3 percent on September 22, 2026, according to Zacks. Sartorius stock therefore remained tied to a broad technology-led market session while its U.S. quote showed a 1.26 percent gain.

After the bell today

The U.S. earnings calendar for September 22, 2026 listed Aytu BioPharma, KB Home and Worthington Enterprises for reports after the market close, not Sartorius. AskTheDate identified those after-hours reports. Sartorius stock remains subject to the next U.S. trading session and any company-specific release published after the bell.

Disclaimer...

en | DE0007165631 | SARTORIUS | boerse | 70159892 | bgmi